Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases

With the emergence of precision medicine, treatment strategies for neurodegenerative diseases are becoming increasingly tailored to individual patients based on their genetic, molecular, and clinical profiles. This session will highlight biomarker-driven clinical trials, pharmacogenomics, and AI-powered patient stratification in developing personalized interventions. Case studies of successful precision medicine approaches in Alzheimer’s, Parkinson’s, and ALS will be presented. This session is valuable for clinicians, researchers, and biotech professionals involved in personalized neurology care.

    Related Conference of Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases

    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    June 22-23, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    July 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE

    Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in